These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 56830

  • 1. [Changes in heparinocytes during the administration of Depositon and Sequenz-Ovosiston].
    Frick G, Göretzlehner G.
    Zentralbl Gynakol; 1975; 97(8):488-93. PubMed ID: 56830
    [Abstract] [Full Text] [Related]

  • 2. [Changes in the heparinocyte count during intake of hormonal contraceptives].
    Frick G, Kühne D.
    Zentralbl Gynakol; 1973 Oct 12; 95(41):1441-50. PubMed ID: 4129504
    [No Abstract] [Full Text] [Related]

  • 3. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
    Vesper VB, Feustel S.
    Zentralbl Gynakol; 1988 Oct 12; 110(4):241-5. PubMed ID: 2453102
    [Abstract] [Full Text] [Related]

  • 4. [Demonstration of fibrinolytic split products during administration of hormonal contraceptives].
    Frick G, Göretzlehner G, Frick U.
    Zentralbl Gynakol; 1975 Oct 12; 97(16):1001-7. PubMed ID: 1199513
    [Abstract] [Full Text] [Related]

  • 5. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
    Ebeling K, Kühndel K, Rothe K, Canzler E.
    Z Arztl Fortbild (Jena); 1971 Dec 15; 65(24):1275-8. PubMed ID: 4111418
    [No Abstract] [Full Text] [Related]

  • 6. [Sequenz-Ovosiston as a contraceptive agent].
    Zwahr C.
    Zentralbl Gynakol; 1972 Dec 09; 94(49):1722-5. PubMed ID: 4119508
    [No Abstract] [Full Text] [Related]

  • 7. [Behavior of heparinocytes and of fibrinolytic degradation products after discontinuation of hormonal contraceptives].
    Frick G, Göretzlehner G, Frick U.
    Zentralbl Gynakol; 1976 Dec 09; 98(15):908-13. PubMed ID: 969999
    [Abstract] [Full Text] [Related]

  • 8. [Hormonal contraception--throboembolism and surgical risk].
    Göretzlehner G, Frick G, Frick U.
    Zentralbl Gynakol; 1976 Dec 09; 98(10):600-10. PubMed ID: 961166
    [Abstract] [Full Text] [Related]

  • 9. [Endometrium in "contraception cycle" under Ovosiston].
    Böhm W, Möbius W, Müller W.
    Zentralbl Gynakol; 1969 Oct 25; 91(43):1412-8. PubMed ID: 4100318
    [Abstract] [Full Text] [Related]

  • 10. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M, Beck P.
    Acta Med Hung; 1986 Oct 25; 43(3):301-10. PubMed ID: 2438639
    [Abstract] [Full Text] [Related]

  • 11. [Effect of oral contraceptives on the psyche and on sexuality].
    Nahrendorf G, Carol W, Klinger G.
    Zentralbl Gynakol; 1978 Oct 25; 100(10):632-7. PubMed ID: 79278
    [Abstract] [Full Text] [Related]

  • 12. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
    Zwahr C.
    Dtsch Gesundheitsw; 1970 Nov 19; 25(47):2247-50. PubMed ID: 4099776
    [No Abstract] [Full Text] [Related]

  • 13. Behavior of total complement as a humoral parameter of nonspecific resistance in hormonal contraception and pregnancy.
    Klinger G, Bonow A, Reichenbächer M, Strauch I, Vieweg A, Stelzner A.
    Dtsch Gesundheitsw; 1976 Dec 01; 31(49):2305-8. PubMed ID: 65248
    [Abstract] [Full Text] [Related]

  • 14. Oral contraceptives.
    Maclennan AH.
    Curr Ther (Seaforth); 1987 Dec 01; 28(12):113-22. PubMed ID: 12317413
    [Abstract] [Full Text] [Related]

  • 15. [Pills and minipills].
    Koffel JC.
    Bull Soc Pharm Strasb; 1978 Dec 01; 21(1):43-53. PubMed ID: 12261367
    [Abstract] [Full Text] [Related]

  • 16. [Structure and ultrastructure of the endometrium with the depot contraceptive Depositon].
    Böhm W, Klinger G, Carol W, Hempel E.
    Zentralbl Gynakol; 1977 Dec 01; 99(7):385-91. PubMed ID: 868362
    [Abstract] [Full Text] [Related]

  • 17. [On the influence of hormonal contraception on the secretion of tears (author's transl)].
    Wild H, Benad A.
    Fol Ophthalmol; 1978 Dec 01; 3(1):53-6. PubMed ID: 12261660
    [Abstract] [Full Text] [Related]

  • 18. [LH excretion during the ovulatory cycle and during therapy with various estrogen-gestagen combinations].
    Göretzlehner G, Wilken H.
    Endokrinologie; 1972 Nov 01; 60(3):302-8. PubMed ID: 4121480
    [Abstract] [Full Text] [Related]

  • 19. [Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen)].
    Mikrut W.
    Wiad Lek; 1983 Oct 01; 36(19):1587-92. PubMed ID: 6198806
    [Abstract] [Full Text] [Related]

  • 20. [Reversibility of alterations induced by sexual steroids in various serum protein fractions, following application of hormonal contraceptives (author's transl)].
    Klinger G, Stelzner A, Börner A, Schubert H, Krause G, Scheler R, Tarnick M, Carol W.
    Zentralbl Gynakol; 1980 Oct 01; 102(24):1421-30. PubMed ID: 6164184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.